切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2022, Vol. 18 ›› Issue (04) : 460 -467. doi: 10.3877/cma.j.issn.1673-5250.2022.04.012

论著

实验室指标在早期鉴别诊断脓毒症和川崎病中的应用
陈丽妮, 乔莉娜()   
  1. 四川大学华西第二医院儿童重症监护室、出生缺陷与相关妇儿疾病教育部重点实验室,成都 610041
  • 收稿日期:2022-01-18 修回日期:2022-07-01 出版日期:2022-08-01
  • 通信作者: 乔莉娜

Laboratory indicators in the early differential diagnosis of sepsis and Kawasaki disease

Lini Chen, Lina Qiao()   

  1. Pediatric Intensive Care Unit, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
  • Received:2022-01-18 Revised:2022-07-01 Published:2022-08-01
  • Corresponding author: Lina Qiao
  • Supported by:
    Project of Sichuan Academic and Technology Leadership Training Support([2017]919-23); Sichuan Science and Technology Plan Project(2019YFS0245)
引用本文:

陈丽妮, 乔莉娜. 实验室指标在早期鉴别诊断脓毒症和川崎病中的应用[J]. 中华妇幼临床医学杂志(电子版), 2022, 18(04): 460-467.

Lini Chen, Lina Qiao. Laboratory indicators in the early differential diagnosis of sepsis and Kawasaki disease[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2022, 18(04): 460-467.

目的

探讨早期鉴别诊断脓毒症与川崎病的生物标志物。

方法

选择2017年1月1日至2018年2月28日,于四川大学华西第二医院出院时确诊为脓毒症及川崎病的患儿为研究对象,并分别纳入脓毒症组(n=286)和川崎病组(n=326)。采用Mann-Whitney U秩和检验对2组患儿的白细胞计数(WBC)、中性粒细胞百分比、中性粒细胞绝对计数(ANC)、C反应蛋白(CRP)、血小板计数(PLT)、血红蛋白(Hb),红细胞沉降率(ESR)、降钙素原(PCT)、血小板平均体积(MPV)、凝血酶原时间(PT)、活化部分凝血活酶时间(APTT),天冬氨酸氨基转移酶(AST)、丙氨酸转移酶(ALT)、乳酸脱氢酶(LDH)、白蛋白、血尿素氮(BUN)、血清肌酐(SCr)、D-二聚体(DD)、纤维蛋白原降解物(FDP)、国际正常化比率(INR)、肌钙蛋白I(cTnI)、肌红蛋白(Mb)、N端脑钠肽(NTBNP)、纤维蛋白原(Fg),动脉血氧分压(PaO2)、吸入氧气分数(FiO2)、Na、K、Ca2+、Cl等指标进行统计学分析。采用χ2检验或连续性校正χ2检验对2组患儿病死率、冠状动脉扩张发生率等进行统计学分析。2组患儿的性别构成比比较,差异无统计学意义(P>0.05)。本研究遵循的程序符合2013年修订的《世界医学协会赫尔辛基宣言》的要求。

结果

①脓毒症组患儿年龄小于川崎病组,入院前发热时间短于川崎病组,2组比较,差异均有统计学意义(P<0.05)。②脓毒症组患儿PCT水平高于川崎病组,而中性粒细胞百分比、ANC和ESR水平低于川崎病组,2组分别比较,差异均有统计学意义(P<0.05)。此外,脓毒症组患儿PCT值>0.5 ng/mL及PCT值>2 ng/mL者占比,均高于川崎病组,而CRP水平>30 mg/L、ESR>40 mm/h者占比,均低于川崎病组,2组分别比较,差异均有统计学意义(P<0.05)。③脓毒症组患儿的MPV、AST、LDH、BUN、SCr、Cl、DD、FDP、cTnI、Mb水平,均高于川崎病组,而Hb、PLT、ALT、Fg水平,均低于川崎病组,并且差异亦均有统计学意义(P<0.05)。④2组患儿呼吸系统功能损伤、循环系统功能损伤、消化系统功能损伤、泌尿系统功能损伤、凝血功能异常、血电解质异常、贫血及血小板增多者所占比例比较,差异均有统计学意义(P<0.05)。⑤脓毒症组与川崎病组住院期间患儿死亡率分别为5.2%(15例)与0,并且差异有统计学意义(χ2=17.527,P<0.001)。

结论

儿童脓毒症和川崎病在早期难以鉴别,易被误诊和漏诊。二者虽然很多实验室检查结果类似,但亦有部分实验室结果存在差异。脓毒症患儿的脏器损伤更严重、预后更差。

Objective

To explore biomarkers for early differential diagnosis of sepsis and Kawasaki disease.

Methods

Children diagnosed with sepsis and Kawasaki disease at the discharge from West China Second Hospital, Sichuan University from January 1, 2017 to February 28, 2018 were selected into this study, and they were included into sepsis group (n=286) and Kawasaki disease group (n=326), respectively. The levels of white blood cell count (WBC), absolute neutrophil count (ANC), C-reactive protein (CRP), platelet count (PLT), erythrocyte sedimentation rate (ESR), hemoglobin (Hb), mean platelet volume (MPV), aspartate aminotransferase (AST), alanine transferase (ALT), lactate dehydrogenase (LDH), blood urea nitrogen (BUN), serum creatinine (SCr), D-dimer (DD), fibrinogen degradation (FDP), troponin I (cTnI), myoglobin (Mb), hemoglobin (Hb), fibrinogen (Fg), partial pressure of oxygen in artery (PaO2), fraction of inspired oxygen (FiO2), activated partial thromboplastin time (APTT), international normalized ratio (INR), and other laboratory indexes between two groups were statistically analyzed by Mann-Whitney U rank sum test. The mortality and the incidence of coronary artery dilatation between two groups were statistically analyzed by chi-square test, continuity correction of chi-square test. There was no significant difference in gender ratio between two groups (P>0.05). This study was in line with the World Medical Association Declaration of Helsinki revised in 2013.

Results

The age of children in sepsis group was younger than that in Kawasaki disease group, but the fever duration before admission in sepsis group was shorter than that in Kawasaki disease group, and the differences between two groups were statistically significant (P<0.05). ②The PCT level in sepsis group was higher than that in Kawasaki disease group, but the percentage of neutrophils, ANC and ESR levels were lower than those in Kawasaki disease group, and the differences between two groups were statistically significant (P<0.05). In addition, in sepsis group, the proportion of PCT value >0.5 ng/mL and PCT value >2 ng/mL were higher than those of Kawasaki disease group, while the proportion of CRP level >30 mg/L and ESR >40 mm/h were lower than those of Kawasaki disease group, and the difference between two groups in terms of above indexes were statistically significant (P<0.05). ③The levels of MPV, AST, LDH, BUN, SCr, Cl-, DD, FDP, cTnI and Mb in sepsis group were higher than those in Kawasaki disease group (P<0.05). In addition, the levels of Hb, PLT, ALT and Fg in sepsis group were lower than those in Kawasaki disease group, and the differences between groups were statistically significant (P<0.05). ④There were significant differences in the proportion of respiratory system dysfunction, circulatory system dysfunction, digestive system dysfunction, urinary system dysfunction, coagulation dysfunction, blood electrolyte abnormality, anemia and thrombocytosis between two groups (P<0.05). ⑤The mortality rates of children in sepsis group and Kawasaki disease group were 5.2% (15 cases) and 0, respectively, and the difference was statistically significant (χ2=17.527, P<0.001).

Conclusions

Childhood sepsis and Kawasaki disease are difficult to differentiate in the early stages and are easily misdiagnosed. Although many laboratory results are similar, there are some differences between the two. In children with sepsis, the organ damage is more severe and the prognosis is worse.

表1 2组患儿一般临床资料比较[M(Q1Q3)]
表2 2组患儿入院时炎症指标比较
表3 脓毒症组与川崎病组其他实验室检查指标比较[M(Q1Q3)]
组别 例数 Hb(g/L) PLT(×109/L) MPV(fL) ALT(U/L) AST(U/L) 白蛋白((g/L)
脓毒症组 286 107.0(93.0,115.0) 287.0(197.0,396.2) 9.7(9.0,10.6) 35.0(27.0,48.0) 38.0(31.0,54.0) 37.3(32.5,40.6)
川崎病组 326 110.0(103.0,116.0) 321.5(274.0,395.0) 9.4(8.9,10.1) 40.0(27.0,86.5) 34.0(28.0,53.3) 37.3(34.1,40.8)
Z   -3.727 -3.977 -2.597 -2.503 -2.838 -0.699
P   <0.001 <0.001 0.009 0.012 0.005 0.484
组别 例数 TB(μmol/L) IBIL(μmol/L) LDH(U/L) SCr(μmol/L) BUN(mmol/L) Na(mmol/L)
脓毒症组 286 4.8(2.6,8.3) 4.3(2.4,7.8) 602.0(494.0,815.0) 31.0(26.0,40.0) 3.2(2.2,4.5) 135.8(132.9,138.0)
川崎病组 326 4.9(3.1,7.7) 4.2(2.5,6.1) 515.0(360.0,636.0) 29.0(25.0,34.0) 2.6(2.0,3.3) 136.0(133.4,138.6)
Z   -0.444 -1.443 -6.530 -3.048 -4.715 -1.655
P   0.657 0.149 <0.001 0.002 <0.001 0.098
组别 例数 K(mmol/L) Cl(mmol/L) Ca2+(mmol/L) 血糖(mmol/L) Fg(mg/dL) DD(mg/L)
脓毒症组 286 4.1(3.7,4.5) 102.4(99.2,105.0) 2.3(2.1,2.4) 5.7(4.9,6.4) 391.0(257.0,570.0) 2.3(0.8,4.4)
川崎病组 326 4.1(3.6,4.4) 100.6(97.8,103.0) 2.3(2.2,2.4) 5.5(4.8,6.2) 570.0(455.0,644.0) 1.4(0.9,2.6)
Z   -1.408 -4.649 -0.321 -1.699 -7.021 -2.037
P   0.159 <0.001 0.749 0.089 <0.001 0.042
组别 例数 FDP(μg/L) NTBNP(pg/mL) cTnI(μg/L) Mb(μg/L) 乳酸(mmol/L)
脓毒症组 286 8.7(4.9,17.1) 1 180.0(424.0,3 740.0) 0.012(0.012,0.017) 24.9(16.4,72.9) 1.7(1.2,2.6)
川崎病组 326 7.0(4.4,12.0) 1 010.0(387.0,3 070.0) 0.012(0.012,0.012) 16.2(12.4,25.6) 1.3(1.0,1.6)
Z   -2.283 -0.545 -3.697 -6.131 -1.954
P   0.022 0.586 <0.001 <0.001 0.051
表4 2组患儿影像学及尿常规检查结果比较[%(n/n′)]
表5 2组判断患儿脏器功能损伤情况指标的发生率比较[%(n/n′)]
组别 例数 循环系统功能损伤 消化系统功能损伤
乳酸>2 mmol/L cTnI>0.034 μg/L NTBNP>450 pg/mL AST>基线2倍 ALT>基线2倍 TB>70 μmol/L 白蛋白<30 g/L
脓毒症组 286 38.3(41/107) 18.8(29/154) 73.7(73/99) 10.8(30/279) 7.5(21/279) 2.2(6/278) 13.7(38/278)
川崎病组 326 0(0/8) 5.5(12/218) 72.3(112/155) 8.1(26/322) 13.4(43/322) 0.3(1/320) 7.2(23/321)
χ2   3.241a 16.344 0.067 1.269 5.334 2.931a 6.890
P   0.072 <0.001 0.796 0.260 0.021 0.087 0.009
组别 例数 呼吸系统功能损伤 凝血功能异常
需呼吸支持b PaO2/FiO2<300 mmHg PT延长>3 s APTT延长>10 s INR>1.5 Fg<200 mg/L Fg>400 mg/L
脓毒症组 286 12.9(37/286) 27.6(79/286) 15.7(25/159) 20.8(33/159) 10.8(17/157) 16.8(26/155) 49.0(76/155)
川崎病组 326 0.3(1/326) 2.1(7/326) 1.9(4/216) 4.2(9/216) 1.0(2/205) 0.9(2/215) 83.3(179/215)
χ2   41.732 81.862 24.697 25.338 17.354 32.323 49.247
P   <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
组别 例数 凝血功能异常 泌尿系统功能损害
DD升高 FDP升高 PLT<150×109/L PLT<100×109/L BUN>基线1.5倍 SCr>基线1.5倍
脓毒症组 286 82.2(74/90) 74.4(67/90) 13.6(39/286) 7.7(22/286) 4.3(12/276) 4.3(12/276)
川崎病组 326 92.0(126/137) 65.4(89/136) 2.1(7/326) 0.9(3/326) 0.3(1/310) 0.3(1/310)
χ2   4.926 2.053 28.929 17.832 10.906 10.906
P   0.026 0.152 <0.001 <0.001 0.001 0.001
组别 例数 血电解质异常 Hb<90 g/L PLT>450×109/L
Na<130 mmol/L K<3.5 mmol/L K>5.5 mmol/L Ca2+<2.1 mmol/L
脓毒症组 286 10.5(29/276) 19.6(54/276) 3.3(9/276) 17.9(49/273) 21.3(61/286) 17.5(50/286)
川崎病组 326 4.8(15/311) 19.3(60/311) 0.3(1/311) 5.8(18/311) 4.6(15/326) 14.1(46/326)
χ2   6.814 0.007 5.891a 21.169 39.194 1.310
P   0.009 0.934 0.015a <0.001 <0.001 0.252
[1]
de Souza DC, Barreira ER, Faria LS. The epidemiology of sepsis in childhood[J]. Shock, 2017, 47(suppl 1): 2-5. DOI: 10.1097/SHK.0000000000000699.
[2]
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315(8): 801-810. DOI: 10.1001/jama.2016.0287.
[3]
陈丽妮,罗黎力,李德渊,等. 尿源性脓毒症患儿的临床特点分析[J/OL]. 中华妇幼临床医学杂志(电子版)2019, 15(3): 292-299. DOI: 10.3877/cma.j.issn.1673-5250.2019.03.009.
[4]
McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of kawasaki disease: a scientific statement for health professionals from the American Heart Association[J]. Circulation, 2017, 135(17): e927-e999. DOI: 10.1161/CIR.0000000000000484.
[5]
中华医学会儿科学分会急救学组. 儿童脓毒性休克(感染性休克)诊治专家共识(2015版)[J]. 中华儿科杂志2015, 22(11): 739-743. DOI: 10.3760/cma.j.issn.1673-4912.2015.11.001.
[6]
Murri R, Taddei E, Cauda R, et al. Use of procalcitonin as a tool for antibiotic stewardship[J]. Future Microbiol, 2019, 14: 77-79. DOI: 10.2217/fmb-2018-0326.
[7]
降钙素原急诊临床应用专家共识组. 降钙素原(PCT)急诊临床应用的专家共识[J]. 中华急诊医学杂志2012, 21(9): 8. DOI: 10.3760/cma.j.issn.1671-0282.2012.09.005.
[8]
Ae R, Abrams JY, Maddox RA, et al. Platelet count variation and risk for coronary artery abnormalities in Kawasaki disease[J]. Pediatr Infect Dis J, 2020, 39(3): 197-203. DOI: 10.1097/INF.0000000000002563
[9]
Kobayashi T, Inoue Y, Takeuchi K, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease[J]. Circulation, 2006, 113(22): 2606-2612. DOI: 10.1161/CIRCULATIONAHA.105.592865.
[10]
Han SB, Lee SY. Differentiating Kawasaki disease from urinary tract infection in febrile children with pyuria and C-reactive protein elevation[J]. Ital J Pediatr, 2018, 44(1): 137. DOI: 10.1186/s13052-018-0585-7.
[11]
Kakihana Y, Ito T, Nakahara M, et al. Sepsis-induced myocardial dysfunction: pathophysiology and management[J]. J Intensive Care, 2016, 4: 22. DOI: 10.1186/s13052-018-0585-7.
[12]
Cui J, Xiong J, Zhang Y, et al. Serum lactate dehydrogenase is predictive of persistent organ failure in acute pancreatitis[J]. J Crit Care, 2017, 41: 161-165. DOI: 10.1016/j.jcrc.2017.05.001
[13]
Matsubara T, Yamakawa K, Umemura Y, et al. Significance of plasma fibrinogen level and antithrombin activity in sepsis: a multicenter cohort study using a cubic spline model[J]. Thromb Res, 2019, 181: 17-23. DOI: 10.1016/j.thromres.2019.07.002.
[14]
Mitra P, Guha D, Nag SS, et al. Role of plasma fibrinogen in diagnosis and prediction of short term outcome in neonatal sepsis[J]. Indian J Hematol Blood Transfus, 2017, 33(2): 195-199. DOI: 10.1007/s12288-016-0683-x.
[15]
臧学峰,陈炜,盛博,等. 早期心脏超声联合心脏生物学标志物预测严重脓毒症的价值:一项5年的单中心回顾性研究[J]. 中华危重病急救医学201830 (4): 332-336. DOI: 10.3760/cma.j.issn.2095-4352.2018.04.009.
[16]
Vallabhajosyula S, Pruthi S, Shah S, et al. Basic and advanced echocardiographic evaluation of myocardial dysfunction in sepsis and septic shock[J]. Anaesth Intensive Care, 2018, 46(1): 13-24. DOI: 10.1177/0310057X1804600104.
[17]
王文,罗钢,张乾忠. 川崎病并发冠状动脉损害19例临床分析[J]. 中国实用儿科杂志2016, 31(11): 843-846. DOI: 10.7504/ek2016110611.
[18]
Liu X, Wang L, Shao S, et al. Sterile pyuria in Kawasaki disease: a large prospective Cohort study[J]. Front Cardiovasc Med, 2022, 9: 856144. DOI: 10.3389/fcvm.2022.856144.
[19]
Yoon SH, Kim DS, Ahn JG. Early features of Kawasaki disease with pyuria in febrile infants younger than 6 months[J]. BMC Pediatr, 2018, 18(1): 389. DOI: 10.1186/s12887-018-1362-x.
[20]
Singh S, Gupta A, Jindal AK, et al. Pulmonary presentation of Kawasaki disease: a diagnostic challenge[J]. Pediatr Pulmonol, 2018, 53(1): 103-107. DOI: 10.1002/ppul.23885.
[1] 张璇, 马宇童, 苗玉倩, 张云, 吴士文, 党晓楚, 陈颖颖, 钟兆明, 王雪娟, 胡淼, 孙岩峰, 马秀珠, 吕发勤, 寇海燕. 超声对Duchenne肌营养不良儿童膈肌功能的评价[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1068-1073.
[2] 张宝富, 俞劲, 叶菁菁, 俞建根, 马晓辉, 刘喜旺. 先天性原发隔异位型肺静脉异位引流的超声心动图诊断[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1074-1080.
[3] 韩丹, 王婷, 肖欢, 朱丽容, 陈镜宇, 唐毅. 超声造影与增强CT对儿童肝脏良恶性病变诊断价值的对比分析[J]. 中华医学超声杂志(电子版), 2023, 20(09): 939-944.
[4] 刘婷婷, 林妍冰, 汪珊, 陈幕荣, 唐子鉴, 代东伶, 夏焙. 超声衰减参数成像评价儿童代谢相关脂肪性肝病的价值[J]. 中华医学超声杂志(电子版), 2023, 20(08): 787-794.
[5] 周钰菡, 肖欢, 唐毅, 杨春江, 周娟, 朱丽容, 徐娟, 牟芳婷. 超声对儿童髋关节暂时性滑膜炎的诊断价值[J]. 中华医学超声杂志(电子版), 2023, 20(08): 795-800.
[6] 米洁, 陈晨, 李佳玲, 裴海娜, 张恒博, 李飞, 李东杰. 儿童头面部外伤特点分析[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 511-515.
[7] 姚咏明. 如何精准评估烧伤脓毒症患者免疫状态[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 552-552.
[8] 王蕾, 王少华, 牛海珍, 尹腾飞. 儿童腹股沟疝围手术期风险预警干预[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 768-772.
[9] 李芳, 许瑞, 李洋洋, 石秀全. 循证医学理念在儿童腹股沟疝患者中的应用[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 782-786.
[10] 彭永辉, 张文杰, 李炳根, 聂向阳, 吴凯, 杨六成. 单孔双针疝囊高位结扎术在儿童巨大腹股沟疝的临床应用[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(05): 566-569.
[11] 吕垒, 冯啸, 何凯明, 曾凯宁, 杨卿, 吕海金, 易慧敏, 易述红, 杨扬, 傅斌生. 改良金氏评分在儿童肝豆状核变性急性肝衰竭肝移植手术时机评估中价值并文献复习[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 661-668.
[12] 卓少宏, 林秀玲, 周翠梅, 熊卫莲, 马兴灶. CD64指数、SAA/CRP、PCT联合检测在小儿消化道感染性疾病鉴别诊断中的应用[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 505-509.
[13] 刘笑笑, 张小杉, 刘群, 马岚, 段莎莎, 施依璐, 张敏洁, 王雅晳. 中国学龄前儿童先天性心脏病流行病学研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1021-1024.
[14] 李静, 张玲玲, 邢伟. 兴趣诱导理念用于小儿手术麻醉诱导前的价值及其对家属满意度的影响[J]. 中华临床医师杂志(电子版), 2023, 17(07): 812-817.
[15] 谭睿, 王晶, 於江泉, 郑瑞强. 脓毒症中高密度脂蛋白、载脂蛋白A-I和血清淀粉样蛋白A的作用研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(06): 749-753.
阅读次数
全文


摘要